Resultados de la búsqueda

Gomez-Moreno D, Adrover JM, Hidalgo A. Neutrophils as effectors of vascular inflammation. Eur J Clin Invest (2018) 48:e12940
Link to the full text in Repisalud
Blazquez R, Sanchez-Margallo FM, Alvarez V, Matilla E, Hernandez N, Marinaro F, Gomez-Serrano M, Jorge I, Casado JG, Macias-Garcia B. Murine embryos exposed to human endometrial MSCs-derived extracellular vesicles exhibit higher VEGF/PDGF AA release, increased blastomere count and hatching rates. PLoS One (2018) 13:e0196080
Link to the full text in Repisalud
Del Monte A, Arroyo AB, Andres-Manzano MJ, Garcia-Barbera N, Caleprico MS, Vicente V, Roldan V, Gonzalez-Conejero R, Martinez C, Andres V. miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis. PLoS One (2018) 13:e0198932
Link to the full text in Repisalud
Garrido F, Pacheco M, Vargas-Martinez R, Velasco-Garcia R, Jorge I, Serrano H, Portillo F, Vazquez J, Pajares MA. Identification of hepatic protein-protein interaction targets for betaine homocysteine S-methyltransferase. PLoS One (2018) 13:e0199472
Link to the full text in Repisalud
Abella M, de Molina C, Ballesteros N, Garcia-Santos A, Martinez A, Garcia I, Desco M. Enabling tomography with low-cost C-arm systems. PLoS One (2018) 13:e203817
Link to the full text in Repisalud
Garcia-Lopez S, Albo-Castellanos C, Urdinguio RG, Canon S, Sanchez-Cabo F, Martinez-Serrano A, Fraga MF, Bernad A. Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells. PLoS One (2018) 13:e0206534
Link to the full text in Repisalud
Salguero-Jimenez A, Grego-Bessa J, D'Amato G, Jimenez-Borreguero LJ, de la Pompa JL. Myocardial Notch1-Rbpj deletion does not affect NOTCH signaling, heart development or function. PLoS One (2018) 13:e0203100
Link to the full text in Repisalud
Rossello X, Pinero A, Fernandez-Jimenez R, Sanchez-Gonzalez J, Pizarro G, Galan-Arriola C, Lobo-Gonzalez M, Vilchez JP, Garcia-Prieto J, Garcia-Ruiz JM, Garcia-Alvarez A, Sanz-Rosa D, Ibanez B. Mirabegron, a Clinically Approved beta3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction. J Cardiovasc Transl Res (2018) 11:310-8
Link to the full text in Repisalud

Páginas